AlphaYouST
Insider selling
Seshu Tyagarajan sold $70K of Candel Therapeutics, Inc. (CADL) stock
Seshu Tyagarajan, Chief Technology Officer of Candel Therapeutics, Inc. (CADL), sold 7,000 shares of CADL stock worth $70K, per an SEC Form 4 filed Jul 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 29, 2026, 2 days before it was made public.
CADL has moved -4.7% since the trade date, from $10.36 to $9.87 (Oct 6, 2026 close).
- Traded
- Jun 29, 2026
- Disclosed
- Jul 1, 2026
- Filing delay
- 2 days
- Price since
- -4.7%
- Role
- Chief Technology Officer
- Source
- SEC Form 4
More CADL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.